Cited by 252

The DOI matches its Crossref record.

A Novel Highly Specific and Potent Inhibitor of Calmodulin-Dependent Protein Kinase II

Ishida, A., Kameshita, I., Okuno, S., Kitani, T., Fujisawa, H.·1995·Biochemical and Biophysical Research Communications

Abstract

A novel synthetic peptide AIP (autocamtide-2-related inhibitory peptide), a nonphosphorylatable analog of autocamtide-2, was found to be a highly specific and potent inhibitor of calmodulin-dependent protein kinase II (CaM-kinase II). It was 50 and 500 times more potent than CaMK-(281-302Ala286) and KN-93, respectively, under the assay conditions used. The inhibition was unaffected by the presence or absence of Ca2+/calmodulin, and it was competitive with autocamtide-2 and noncompetitive with syntide-2. AIP (1 microM) completely inhibited CaM-kinase II activity, but did not affect cyclic AMP-dependent protein kinase, protein kinase C, calmodulin-dependent protein kinase IV, and unidentified protein kinases occurring in a rat brain extract. These results indicate that AIP is a useful tool for studying the physiological roles of CaM-kinase II.

Overview

Integrity signals

Registry

Crossref · 10.1006/bbrc.1995.2040

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • CaMKII inhibition with AIP blocks cLTP-induced SNX17 recruitment to synapses, whereas PKA inhibition with KT5720 and ERK inhibition with U0126 do not.

    “We found that autocamtide-2-related inhibitory peptide (AIP), a selective and potent inhibitor of CaMKII (Ishida et al., 1995), blocked SNX17 recruitment to synapses upon cLTP stimulation. However, both KT5720 and U0126, which inhibit PKA- and ERK- dependent signaling pathways, respectively, failed to block cLTP-dependent SNX17 recruitment (Fig. 4 E).”
  • AIP is a selective and potent inhibitor of CaMKII.

    “autocamtide-2-related inhibitory peptide (AIP), a selective and potent inhibitor of CaMKII (Ishida et al., 1995)”

Citations

Cited by

Sorted by citations

Metadata

Authors
Ishida, A., Kameshita, I., Okuno, S., Kitani, T., & Fujisawa, H.
Venue
Biochemical and Biophysical Research Communications
Publisher
Elsevier BV
Published
1995-07
Volume
212
Issue
3
Pages
806-812
ISSN
0006-291X
Cited by
252
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review